Year archive

MicroPort CardioFlow Medtech Corporation — 2024 filings

All 44 regulatory filings released by MicroPort CardioFlow Medtech Corporation (2160) in 2024, sourced directly from the official regulator.

44 Filings

2024 Period

2024 filings (44)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - NMPA APPROVAL FOR REGISTRATION OF VITAFLOW LIBERTY FLEX Regulatory Filings	2024-12-17	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-07	English
PROVISION OF GUARANTEES FOR MP CARDIOADVENT AND REVISION OF ANNUAL CAP FOR CONTINUING CONNECTED TRANSACTIONS UNDER THE 2023 MASTER SERVICE PROCUREMENT AGREEMENT Capital/Financing Update	2024-09-30	English
2024 Interim Report Interim / Quarterly Report H1 2024	2024-09-26	English
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 20, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-09-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-05	English
Documents on Display Regulatory Filings	2024-08-29	English
FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, SEPTEMBER 20, 2024 Proxy Solicitation & Information Statement	2024-08-29	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-08-29	English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST OF THE TARGET COMPANY AND NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-08-29	English
ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report H1 2024	2024-08-28	English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE EQUITY INTEREST OF THE TARGET COMPANY M&A Activity	2024-08-22	English
DATE OF BOARD MEETING Report Publication Announcement	2024-08-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-05	English
PROFIT FORECAST FOR THE FIRST HALF OF 2024 - SIGNIFICANT REDUCTION IN NET LOSS OF APPROXIMATELY 63% TO 72% Regulatory Filings	2024-07-24	English
Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Report Publication Announcement	2024-07-22	English
Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-07-22	English
CONTINUING CONNECTED TRANSACTION IN RELATION TO THE 2024 KEWEI DISTRIBUTION FRAMEWORK AGREEMENT AND CONNECTED TRANSACTION IN RELATION TO THE KEWEI LOAN AGREEMENT Regulatory Filings	2024-07-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-05	English
ESTIMATED INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND BUSINESS UPDATE Interim / Quarterly Report H1 2024	2024-07-04	English
SIXTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2024-06-26	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 26, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-06	English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 26, 2024 AGM Information	2024-05-31	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2024-05-31	English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES (EXCLUDING TREASURY SHARES) AND TO ISSUE NEW SHARES (INCLUDING SALE OR TRANSFER OF TREASURY SHARES); (2) PROPOSED RE-ELECTION OF THE Proxy Solicitation & Information Statement	2024-05-31	English
VOLUNTARY ANNOUNCEMENT - ALTAVALVE WAS GRANTED THE BREAKTHROUGH DEVICE DESIGNATION BY THE FDA Regulatory Filings	2024-05-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Share Issue/Capital Change	2024-05-07	English
2023 Annual Report Annual Report FY 2023	2024-04-26	English
VOLUNTARY ANNOUNCEMENT - CE MARK APPROVAL OF VITAFLOW LIBERTY Regulatory Filings	2024-04-25	English
CONTINUING CONNECTED TRANSACTION IN RELATION TO 2024 MP CARDIOADVENT SERVICE PROCUREMENT FRAMEWORK AGREEMENT Regulatory Filings	2024-04-15	English
GRANT OF SHARE OPTIONS Capital/Financing Update	2024-04-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-08	English
PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2024-03-27	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 Annual Report FY 2023	2024-03-27	English
DATE OF BOARD MEETING Report Publication Announcement	2024-03-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Share Issue/Capital Change	2024-03-06	English
ESTIMATED ANNUAL RESULTS FOR THE YEAR 2023 AND BUSINESS UPDATE Earnings Release FY 2023	2024-02-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-06	English
VOLUNTARY ANNOUNCEMENT - NMPA APPROVAL FOR REGISTRATION APPLICATION OF ANCHORMAN LAAC SYSTEM Regulatory Filings	2024-01-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-05	English
CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF 51% EQUITY INTEREST IN MP CARDIOADVENT AND CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING Capital/Financing Update	2024-01-01	English